Challenges for Drug Repurposing in Covid-19


The corona virus disease (COVID-19) contagion has affected an estimated 16 million persons and caused 0.6 million deaths worldwide by September 2020. The contagion has led to a rush to repurpose existing drugs, although the elementary substantiation base is of variable quality. The enriching knowledge of the virology and clinical presentation of COVID-19 is leading to a broadening pool of implicit pharmacological targets. The intention is to describe executive and pharmacological aspects of medicine repurposing and to identify medicines proposed for repurposing in COVID-19 hung on registered clinical trials, bandying the substantiation to support their use in the treatment of this distemper. The challenges of the correct interpretation of breathing pre-clinical/ clinical substantiation as well as the generation of new substantiation concerning medicine repurposing in COVID-19 will also be agitated


  • SARS-CoV-2 Mpro
  • Functional Fine-Tuning of Metabolic Pathways by the Endocannabinoid System-Implications for Health and Disease.
  • Cytokine storm modulation in COVID-19: a proposed role for vitamin D and DPP-4 inhibitor combination therapy (VIDPP-4i)
  • Drug Repurposing in the COVID-19 Era

Related Conference of Challenges for Drug Repurposing in Covid-19

May 09-10, 2024

4th Global Summit on Pharmaceutical Research

Barcelona, Spain
May 16-17, 2024

18th World Drug Delivery Summit

Rome, Italy
May 30-31, 2024

9th Pharmaceutical Chemistry Conference

Paris, France
July 25-26, 2024

34th Annual European Pharma Congress

Frankfurt, Germany
September 11-12, 2024

9th International Conference on Future Pharma and Innovations

Amsterdam, Netherlands
September 25-26, 2024

4th World Congress on Rare Diseases & Orphan Drugs

Paris, France
November 26-27, 2024

3rd World Conference on Pharma Industry and Medical Devices

Zurich, Switzerland
November 26-27, 2024

3rd World Congress on Precision and Personalized Medicine

Zurich, Switzerland
November 28-29, 2024

4th International Conference on Pharmaceutical Chemistry

Bali, Indonesia
November 28-29, 2024

39th World Congress on Pharmacology and Therapeutics

Paris, France
November 28-29, 2024

12th International Conference on Clinical Trials

Vancouver, Canada
December 05-06, 2024

17th World Drug Delivery Summit

Dubai, UAE

Challenges for Drug Repurposing in Covid-19 Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in